SLI Medical Acceptable Dating: we will ship >= 180 days
Quantity
4 per Box
Storage Requirements
Requires Refrigeration
Strength
200 mg / mL
Type
Subcutaneous
UNSPSC Code
51202403
Features
BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: patients aged 5 years and older with active
autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy
BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: adult patients with active lupus nephritis who are receiving standard therapy.
BENLYSTA (belimumab) injection is a clear to opalescent
and colorless to pale yellow solution for subcutaneous use. Each single-dose prefilled syringe is designed to deliver 200 mg of belimumab in 1 mL of solution and is supplied as follows: 200 mg/mL single-dose prefilled glass syringe with 27-gauge
half-inch needle attached in a carton of 4 (NDC 49401-088-47).
Requires Refrigeration
